New patent for Loxo Oncology drug RETEVMO

October 27, 2020 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncology Inc and is included in one NDA. It is available from one supplier. There are four…

The post New patent for Loxo Oncology drug RETEVMO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.